CBD Leads to Nonseizure Improvements, AbbVie Launches 24-Hour Levodopa Infusion in EU, CNM-Au8 Improves Visual Function and Cognition

WATCH TIME: 4 minutes Welcome to this special edition of Neurology News Network. I’m Marco Meglio. In a survey study of patients with either Lennox-Gastaut syndrome or Dravet syndrome, findings showed that treatment with add-on cannabidiol (CBD; Epidiolex) led to improvements in nonseizure outcomes, regardless of reduction in seizure frequency. ... Read More